Factors associated with the use of benzodiazepine and opioid prescription drug in the student population: a cross-sectional study.
Humans
Benzodiazepines
/ adverse effects
Female
Male
Cross-Sectional Studies
Analgesics, Opioid
/ adverse effects
Young Adult
Students
/ psychology
Adult
Adolescent
Substance-Related Disorders
/ epidemiology
Surveys and Questionnaires
France
/ epidemiology
Prescription Drug Misuse
/ statistics & numerical data
Prescription Drugs
Attention Deficit Disorder with Hyperactivity
/ epidemiology
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
06 06 2024
06 06 2024
Historique:
received:
04
01
2024
accepted:
23
05
2024
medline:
7
6
2024
pubmed:
7
6
2024
entrez:
6
6
2024
Statut:
epublish
Résumé
The misuse of benzodiazepines and opioid medications is frequent in students. To improve our understanding of this behavior, we aimed to identify factors associated with separate and concomitant use of these substances. Anonymous self-reported questionnaires were e-mailed to students enrolled at a French university between March and July 2021, covering: sociodemographic characteristics, academics, psychoactive substance use, ADHD symptomatology (adulthood and childhood), and psychiatric/psychological or addiction follow-up. Factors associated with the use of benzodiazepines and opioid medications included female sex (OR = 1.41 [1.08; 1.86]) and OR = 1.38 [1.06; 1.79], respectively), older age (OR = 1.65 [1.04; 2.6] and OR = 2.17 [1.4; 3.36], respectively), current psychiatric/psychological follow-up (OR = 6.53 [5.18; 8.24] and OR= 1.5 [1.12; 2.0], respectively), ADHD symptomatology (OR= 2.33 [1.71;3.16] and OR= 1.61 [1.15; 2.24], respectively), polyconsumption (tobacco use for benzodiazepine users, OR = 1.38 [1.04; 1.82]; alcohol use OR = 1.67 [1.17; 2.39] and tobacco use OR = 1.62 [1.23; 2.14] for opioid users). These factors were even more strongly associated with the concomitant use of benzodiazepines and opioid medications: older age (OR = 3.64 [2.22; 5.99]), female sex (OR = 1.54 [1.1; 2.14]), grade repetition (OR = 1.7 [1.14; 2.54]), psychiatric/psychological follow-up (OR = 4.51 [3.35;6.06]), ADHD symptomatology (OR = 5.3 [3.69; 7.63]), polyconsumption (tobacco use OR = 2.05 [1.39; 3] and cannabis use, OR = 2.07 [1.97; 4.16]. The factors associated with the use of benzodiazepines and prescription opioids identified in this study could lead to the development of targeted prevention methods.
Identifiants
pubmed: 38844771
doi: 10.1038/s41598-024-63037-4
pii: 10.1038/s41598-024-63037-4
doi:
Substances chimiques
Benzodiazepines
12794-10-4
Analgesics, Opioid
0
Prescription Drugs
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
13040Informations de copyright
© 2024. The Author(s).
Références
Liu, E. Y., Tamblyn, R., Filion, K. B. & Buckeridge, D. L. Concurrent prescriptions for opioids and benzodiazepines and risk of opioid overdose: Protocol for a retrospective cohort study using linked administrative data. BMJ Open https://doi.org/10.1136/bmjopen-2020-042299 (2021).
doi: 10.1136/bmjopen-2020-042299
pubmed: 35099406
pmcid: 8720994
Stein, M. D., Kanabar, M., Anderson, B. J., Lembke, A. & Bailey, G. L. Reasons for benzodiazepine use among persons seeking opioid detoxification. J. Subst. Abuse Treat. 68, 57–61. https://doi.org/10.1016/j.jsat.2016.06.008 (2016).
doi: 10.1016/j.jsat.2016.06.008
pubmed: 27431047
pmcid: 4955948
Cho, J. et al. Risk of overdose with exposure to prescription opioids, benzodiazepines, and non-benzodiazepine sedative-hypnotics in adults: A retrospective cohort study. J. Gen. Intern. Med. 35(3), 696–703. https://doi.org/10.1007/s11606-019-05545-y (2020).
doi: 10.1007/s11606-019-05545-y
pubmed: 31919729
pmcid: 7080944
Votaw, V. R., Geyer, R., Rieselbach, M. M. & McHugh, R. K. The epidemiology of benzodiazepine misuse: A systematic review. Drug Alcohol Depend. 200, 95–114. https://doi.org/10.1016/j.drugalcdep.2019.02.033 (2019).
doi: 10.1016/j.drugalcdep.2019.02.033
pubmed: 31121495
pmcid: 6639084
Bordet, R., Carton, L., Deguil, J. & Dondaine, T. Neuropsychopharmacologie 135–47 (Elsevier Masson, 2019).
doi: 10.1016/B978-2-294-75299-5.00011-3
Dell’Osso, et al. Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatr. Dis. Treat. https://doi.org/10.2147/NDT.S83130 (2015).
doi: 10.2147/NDT.S83130
pubmed: 26257524
pmcid: 4525786
Harkouk, H., Pares, F., Daoudi, K. & Fletcher, D. Pharmacologie des opioïdes. EMC Anesthésie-Réanim. 15, 1–23 (2018).
Batisse, A., Leger, S., Vicaut, E., Gerbaud, L. & Djezzar, S. Cognitive enhancement and consumption of psychoactive substances among youth students (COSYS): A cross-sectional study in France. Public Health 194, 75–8 (2021).
doi: 10.1016/j.puhe.2021.02.036
pubmed: 33865150
Weyandt, L. L. et al. Misuse of prescription stimulants among college students: A review of the literature and implications for morphological and cognitive effects on brain functioning. Exp. Clin. Psychopharmacol. 21(5), 385–407. https://doi.org/10.1037/a0034013 (2013).
doi: 10.1037/a0034013
pubmed: 24099359
Substance Abuse and Mental Health Services Administration. Behavioral Health Among College Students Information & Resource Kit.122. (2019)
Perino, J. et al. Psychoactive substance use among students: A cross-sectional analysis. Fundam. Clin. Pharmacol. 36(5), 908–14. https://doi.org/10.1111/fcp.12771 (2022).
doi: 10.1111/fcp.12771
pubmed: 35194825
pmcid: 9544725
Martinotti, G. et al. Novel psychoactive substances in young adults with and without psychiatric comorbidities. BioMed. Res. Int. 2014, 815424. https://doi.org/10.1155/2014/815424 (2014).
doi: 10.1155/2014/815424
pubmed: 25133182
pmcid: 4123484
Corazza, O. et al. The emergence of exercise addiction, body dysmorphic disorder, and other image-related psychopathological correlates in fitness settings: A cross sectional study. PLoS One 14(4), e0213060. https://doi.org/10.1371/journal.pone.0213060 (2019).
doi: 10.1371/journal.pone.0213060
pubmed: 30943200
pmcid: 6447162
Stogner, J. M., Sanders, A. & Miller, B. L. Deception for drugs: Self-reported « Doctor Shopping » among young adults. J. Am. Board Fam. Med. 27(5), 583–93. https://doi.org/10.3122/jabfm.2014.05.140107 (2014).
doi: 10.3122/jabfm.2014.05.140107
pubmed: 25201928
Schifano, F. et al. Focus on over-the-counter drugs’ misuse: A systematic review on antihistamines, cough medicines, and decongestants. Front. Psychiatry 12, 657397. https://doi.org/10.3389/fpsyt.2021.657397 (2021).
doi: 10.3389/fpsyt.2021.657397
pubmed: 34025478
pmcid: 8138162
Agence nationale de sécurité du médicament et des produits de santé. État des lieux de la consommation des antalgiques opioïdes et leurs usages problématiques. Saint-Denis: ANSM. http://ansm.sante.fr/ (2019)
Micallef, J., Jouanjus, É., Mallaret, M. & Lapeyre, M. M. Détection des signaux du réseau français d’addictovigilance: Méthodes innovantes d’investigation, illustrations et utilité pour la santé publique. Therapies 74(6), 579–90. https://doi.org/10.1016/j.therap.2019.09.005 (2019).
doi: 10.1016/j.therap.2019.09.005
Jouanjus, E. et al. Medical prescription forms of opioid cough suppressants falsified by the patients before and after they switched from over-the-counter to prescription-only in France. Br. J. Clin. Pharmacol. 88(4), 1713–21. https://doi.org/10.1111/bcp.15052 (2022).
doi: 10.1111/bcp.15052
pubmed: 34427950
Carton, L. et al. Pharmaceutical cognitive doping in students: A chimeric way to get-a-head?. Therapies 73(4), 331–339. https://doi.org/10.1080/19585969.2023.2268063 (2018).
doi: 10.1080/19585969.2023.2268063
Munro, B. A., Weyandt, L. L., Marraccini, M. E. & Oster, D. R. The relationship between nonmedical use of prescription stimulants, executive functioning and academic outcomes. Addict. Behav. 65, 250–7. https://doi.org/10.1016/j.addbeh.2016.08.023 (2017).
doi: 10.1016/j.addbeh.2016.08.023
pubmed: 27567397
Mochrie, K. D., Whited, M. C., Cellucci, T., Freeman, T. & Corson, A. T. ADHD, depression, and substance abuse risk among beginning college students. J. Am. Coll. Health 68(1), 6–10. https://doi.org/10.1080/07448481.2018.1515754 (2020).
doi: 10.1080/07448481.2018.1515754
pubmed: 30257141
Romo, L. et al. Attention-deficit hyperactivity disorder and addictions (substance and behavioral): Prevalence and characteristics in a multicenter study in France. J. Behav. Addict. 7(3), 743–51. https://doi.org/10.1556/2006.7.2018.58 (2018).
doi: 10.1556/2006.7.2018.58
pubmed: 30010409
pmcid: 6426372
Weyandt, L. L. et al. Prescription opioid misuse among university students: A systematic review. J. Am. Coll. Health ACH 70(4), 1119–37. https://doi.org/10.1080/07448481.2020.1786095 (2022).
doi: 10.1080/07448481.2020.1786095
Maust, D. T., Lin, L. A. & Blow, F. C. Benzodiazepine use and misuse among adults in the United States. Psychiatr. Serv. Wash. DC 70(2), 97–106. https://doi.org/10.1176/appi.ps.201800321 (2019).
doi: 10.1176/appi.ps.201800321
Weyandt, L. L. et al. Nonmedical prescription opioid use among a sample of college students: Prevalence and predictors. Pharmacy 9(2), 106. https://doi.org/10.3390/pharmacy9020106 (2021).
doi: 10.3390/pharmacy9020106
pubmed: 34071670
pmcid: 8167772
Carton, L. et al. An overview of the use of psychoactive substances among students at the University of Lille during the COVID-19 health crisis: Results of the PETRA study. Dialog. Clin. Neurosci. 25, 101–11. https://doi.org/10.1080/19585969.2023.2268063 (2023).
doi: 10.1080/19585969.2023.2268063
Ramón-Arbués, E. et al. The prevalence of depression, anxiety and stress and their associated factors in college students. Int. J. Environ. Res. Public Health 17(19), 7001. https://doi.org/10.3390/ijerph17197001 (2020).
doi: 10.3390/ijerph17197001
pubmed: 32987932
pmcid: 7579351
Kessler, R. C. et al. The World Health Organization adult ADHD self-report scale (ASRS): A short screening scale for use in the general population. Psychol. Med. 35, 245–56. https://doi.org/10.1017/s0033291704002892 (2005).
doi: 10.1017/s0033291704002892
pubmed: 15841682
Caci, H. M., Bouchez, J. & Baylé, F. J. An aid for diagnosing attention-deficit/hyperactivity disorder at adulthood: Psychometric properties of the French versions of two Wender Utah Rating Scales (WURS-25 and WURS-K). Compr. Psychiatry 51, 325–31. https://doi.org/10.1016/j.comppsych.2009.05.006 (2010).
doi: 10.1016/j.comppsych.2009.05.006
pubmed: 20399344
Venables, W. N., Ripley, B. D. & Venables, W. N. Modern Applied Statistics with S 4th edn, 495 (Springer, 2002).
doi: 10.1007/978-0-387-21706-2
Schepis, T. S., Klare, D. L., Ford, J. A. & McCabe, S. E. Prescription drug misuse: Taking a lifespan perspective. Subst. Abuse Res. Treat. https://doi.org/10.1177/1178221820909352 (2020).
doi: 10.1177/1178221820909352
Agence nationale de sécurité du médicament et des produits de santé. État des lieux de la consommation des benzodiazépines en France. Saint-Denis: ANSM, p. 82. https://ansm.sante.fr/ (2017).
Schepis, T. S., Wastila, L. & McCabe, S. E. Prescription tranquilizer/sedative misuse motives across the US population. J. Addict. Med. 15(3), 191–200. https://doi.org/10.1097/ADM.0000000000000736 (2021).
doi: 10.1097/ADM.0000000000000736
pubmed: 32909984
pmcid: 7937768
Di Nicola, M. et al. Gender differences and psychopathological features associated with addictive behaviors in adolescents. Front. Psychiatry 8, 256. https://doi.org/10.3389/fpsyt.2017.00256 (2017).
doi: 10.3389/fpsyt.2017.00256
pubmed: 29249992
pmcid: 5716988
Homish, G. G., Leonard, K. E. & Cornelius, J. R. Individual, partner and relationship factors associated with non-medical use of prescription drugs. Addiction 105(8), 1457–65. https://doi.org/10.1111/j.1360-0443.2010.02986.x (2010).
doi: 10.1111/j.1360-0443.2010.02986.x
pubmed: 20528812
pmcid: 3670616
DuPaul, G. J., Weyandt, L. L., O’Dell, S. M. & Varejao, M. College students with ADHD: Current status and future directions. J. Atten. Disord. 13(3), 234–50. https://doi.org/10.1177/1087054709340650 (2009).
doi: 10.1177/1087054709340650
pubmed: 19620623
Smith, N. R. et al. Adolescent mental health difficulties and educational attainment: Findings from the UK household longitudinal study. BMJ Open https://doi.org/10.1136/bmjopen-2020-046792 (2021).
doi: 10.1136/bmjopen-2020-046792
pubmed: 37010923
pmcid: 8719220
Weyandt, L. L., Oster, D. R., Gudmundsdottir, B. G., DuPaul, G. J. & Anastopoulos, A. D. Neuropsychological functioning in college students with and without ADHD. Neuropsychology 31(2), 160–72. https://doi.org/10.1037/neu0000326 (2017).
doi: 10.1037/neu0000326
pubmed: 27831696
McCloud, T. & Bann, D. Financial stress and mental health among higher education students in the UK up to 2018: Rapid review of evidence. J. Epidemiol. Community Health 73(10), 977–84. https://doi.org/10.1136/jech-2019-212154 (2019).
doi: 10.1136/jech-2019-212154
pubmed: 31406015
Wasserman, D. et al. School-based suicide prevention programmes: the SEYLE cluster-randomised, controlled trial. Lancet 385(9977), 1536–44. https://doi.org/10.1016/S0140-6736(14)61213-7 (2015).
doi: 10.1016/S0140-6736(14)61213-7
pubmed: 25579833
Notredame, C. et al. Prévenir le suicide: Connaissances et interventions. La santé en action 450, 52 (2019).
Wathelet, M. et al. Factors associated with mental health disorders among university students in France confined during the COVID-19 pandemic. JAMA Netw. Open 3(10), e2025591. https://doi.org/10.1001/jamanetworkopen.2020.25591 (2020).
doi: 10.1001/jamanetworkopen.2020.25591
pubmed: 33095252
pmcid: 7584927